Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemistry & Biology|July 29, 2006
A general strategy for creating "inactive-conformation" abl inhibitorsBarun Okram, Advait Nagle, Francisco J Adrián, et al.
Journal of Medicinal Chemistry|September 11, 2010
Expanding the diversity of allosteric bcr-abl inhibitorsXianming Deng, Barun Okram, Qiang Ding, et al.
Nature Chemical Biology|January 17, 2020
Author Correction: Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complexDirksen E Bussiere, Lili Xie, Honnappa Srinivas, et al.
Nature Chemical Biology|December 11, 2019
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complexDirksen E Bussiere, Lili Xie, Honnappa Srinivas, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory DiseasesXiaohui He, Sara Da Ros, John Nelson, et al.
Nature|January 15, 2010
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitorsJianming Zhang, Francisco J Adrián, Wolfgang Jahnke, et al.
Journal of Medicinal Chemistry|May 19, 2026
Targeting Multiple KRAS Mutations with High-Affinity Macrocyclic Inhibitors: From Discovery to Preclinical ValidationDean P Phillips, Phil B Alper, Charles Y Cho, et al.
Pageof 1